Skip to main content
PMC home page
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2002 Jan;19(1):57–62. doi: 10.1136/emj.19.1.57

A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation

T Hassan 1, C Jagger 1, D Barnett 1
PMCID: PMC1725791  PMID: 11777881

Abstract

Study hypothesis: Intravenous magnesium sulphate given early in the resuscitation phase for patients in refractory VF (VF after 3 DC shocks) or recurring VF will significantly improve their outcome, defined as a return of spontaneous circulation (ROSC) and discharge from hospital alive.

Design: A randomised, double blind, placebo controlled trial. Pre-defined primary and secondary endpoints were ROSC at the scene or in accident and emergency (A&E) and discharge from hospital alive respectively.

Setting, participants, and intervention: Patients in CA with refractory or recurrent VF treated in the prehospital phase by the county emergency medical services and/or in the A&E department. One hundred and five patients with refractory VF were recruited over a 15 month period and randomised to receive either 2–4 g of magnesium sulphate or placebo intravenously.

Results: Fifty two patients received magnesium treatment and 53 received placebo. The two groups were matched for most parameters including sex, response time for arrival at scene and airway interventions. There were no significant differences between magnesium and placebo for ROSC at the scene or A&E (17% v 13%). The 4% difference had 95% confidence intervals (CI) ranging from -10% to +18%. For patients being alive to discharge from hospital (4% v 2%) the difference was 2% (95% CI –7% to +11%). After adjustment for potential confounding variables (age, witnessed arrest, bystander cardiopulmonary resuscitation and system response time), the odds ratio (95% CI) for ROSC in patients treated with magnesium as compared with placebo was 1.69 (0.54 to 5.30).

Conclusion: Intravenous magnesium given early in patients suffering CA with refractory or recurrent VF did not significantly improve the proportion with a ROSC or who were discharged from hospital alive.

Full Text

The Full Text of this article is available as a PDF (113.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayés de Luna A., Coumel P., Leclercq J. F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989 Jan;117(1):151–159. doi: 10.1016/0002-8703(89)90670-4. [DOI] [PubMed] [Google Scholar]
  2. Brown C. G., Griffith R. F., Neely D., Hobson J., Miller B. The effect of intravenous magnesium administration on aortic, right atrial and coronary perfusion pressures during CPR in swine. Resuscitation. 1993 Aug;26(1):3–12. doi: 10.1016/0300-9572(93)90157-l. [DOI] [PubMed] [Google Scholar]
  3. Craddock L., Miller B., Clifton G., Krumbach B., Pluss W. Resuscitation from prolonged cardiac arrest with high-dose intravenous magnesium sulfate. J Emerg Med. 1991 Nov-Dec;9(6):469–476. doi: 10.1016/0736-4679(91)90220-a. [DOI] [PubMed] [Google Scholar]
  4. Cummins R. O., Chamberlain D. A., Abramson N. S., Allen M., Baskett P., Becker L., Bossaert L., Delooz H., Dick W., Eisenberg M. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Ann Emerg Med. 1991 Aug;20(8):861–874. [PubMed] [Google Scholar]
  5. Cummins R. O., Ornato J. P., Thies W. H., Pepe P. E. Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation. 1991 May;83(5):1832–1847. doi: 10.1161/01.cir.83.5.1832. [DOI] [PubMed] [Google Scholar]
  6. Eisenberg M. S., Horwood B. T., Cummins R. O., Reynolds-Haertle R., Hearne T. R. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med. 1990 Feb;19(2):179–186. doi: 10.1016/s0196-0644(05)81805-0. [DOI] [PubMed] [Google Scholar]
  7. Fatovich D. M., Prentice D. A., Dobb G. J. Magnesium in cardiac arrest (the magic trial). Resuscitation. 1997 Nov;35(3):237–241. doi: 10.1016/s0300-9572(97)00062-2. [DOI] [PubMed] [Google Scholar]
  8. Fazekas T., Scherlag B. J., Vos M., Wellens H. J., Lazzara R. Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin Cardiol. 1993 Nov;16(11):768–774. doi: 10.1002/clc.4960161105. [DOI] [PubMed] [Google Scholar]
  9. Hassan T. B., Barnett D. B. Magnesium in in-hospital cardiac arrest. Lancet. 1998 Feb 7;351(9100):445–446. doi: 10.1016/S0140-6736(05)78390-2. [DOI] [PubMed] [Google Scholar]
  10. Hassan T. B., Hickey F. G., Goodacre S., Bodiwala G. G. Prehospital cardiac arrest in Leicestershire: targeting areas for improvement. J Accid Emerg Med. 1996 Jul;13(4):251–255. doi: 10.1136/emj.13.4.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herlitz J., Bång A., Holmberg M., Axelsson A., Lindkvist J., Holmberg S. Rhythm changes during resuscitation from ventricular fibrillation in relation to delay until defibrillation, number of shocks delivered and survival. Resuscitation. 1997 Feb;34(1):17–22. doi: 10.1016/s0300-9572(96)01064-7. [DOI] [PubMed] [Google Scholar]
  12. Horner S. M. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation. 1992 Sep;86(3):774–779. doi: 10.1161/01.cir.86.3.774. [DOI] [PubMed] [Google Scholar]
  13. Iseri L. T., Allen B. J., Brodsky M. A. Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium. 1989;8(5-6):299–306. [PubMed] [Google Scholar]
  14. Meyer S., Gibb T., Jurkovich G. J. Evaluation and significance of the pupillary light reflex in trauma patients. Ann Emerg Med. 1993 Jun;22(6):1052–1057. doi: 10.1016/s0196-0644(05)82750-7. [DOI] [PubMed] [Google Scholar]
  15. Miller B., Craddock L., Hoffenberg S., Heinz S., Lefkowitz D., Callender M. L., Battaglia C., Maines C., Masick D. Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies. Resuscitation. 1995 Aug;30(1):3–14. doi: 10.1016/0300-9572(95)00868-t. [DOI] [PubMed] [Google Scholar]
  16. Pepe P. E., Abramson N. S., Brown C. G. ACLS--does it really work? Ann Emerg Med. 1994 May;23(5):1037–1041. doi: 10.1016/s0196-0644(94)70100-8. [DOI] [PubMed] [Google Scholar]
  17. Sedgwick M. L., Dalziel K., Watson J., Carrington D. J., Cobbe S. M. Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the 'Utstein Style'. Resuscitation. 1993 Aug;26(1):75–88. doi: 10.1016/0300-9572(93)90166-n. [DOI] [PubMed] [Google Scholar]
  18. Stiell I. G., Wells G. A., Hebert P. C., Laupacis A., Weitzman B. N. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med. 1995 Apr;2(4):264–273. doi: 10.1111/j.1553-2712.1995.tb03220.x. [DOI] [PubMed] [Google Scholar]
  19. Thel M. C., Armstrong A. L., McNulty S. E., Califf R. M., O'Connor C. M. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet. 1997 Nov 1;350(9087):1272–1276. doi: 10.1016/s0140-6736(97)05048-4. [DOI] [PubMed] [Google Scholar]
  20. Tobey R. C., Birnbaum G. A., Allegra J. R., Horowitz M. S., Plosay J. J., 3rd Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulfate administration. Ann Emerg Med. 1992 Jan;21(1):92–96. doi: 10.1016/s0196-0644(05)82249-8. [DOI] [PubMed] [Google Scholar]
  21. White B. C., Winegar C. D., Wilson R. F., Krause G. S. Calcium blockers in cerebral resuscitation. J Trauma. 1983 Sep;23(9):788–794. doi: 10.1097/00005373-198309000-00003. [DOI] [PubMed] [Google Scholar]
  22. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]
  23. Woods K. L. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol. 1991 Jul;32(1):3–10. doi: 10.1111/j.1365-2125.1991.tb05605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES